CN105685759A - Effervescent tablets with lung heat clearing function and preparation method of effervescent tablets - Google Patents
Effervescent tablets with lung heat clearing function and preparation method of effervescent tablets Download PDFInfo
- Publication number
- CN105685759A CN105685759A CN201610138972.6A CN201610138972A CN105685759A CN 105685759 A CN105685759 A CN 105685759A CN 201610138972 A CN201610138972 A CN 201610138972A CN 105685759 A CN105685759 A CN 105685759A
- Authority
- CN
- China
- Prior art keywords
- extract
- heat clearing
- adds
- lung heat
- filtrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007938 effervescent tablet Substances 0.000 title claims abstract description 45
- 210000004072 lung Anatomy 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 49
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 36
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 36
- 210000000582 semen Anatomy 0.000 claims abstract description 36
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims abstract description 32
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 32
- 239000001530 fumaric acid Substances 0.000 claims abstract description 16
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229940094952 green tea extract Drugs 0.000 claims abstract description 11
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 11
- 235000019202 steviosides Nutrition 0.000 claims abstract description 11
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000661 sodium alginate Substances 0.000 claims abstract description 10
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 10
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 10
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 9
- 235000013305 food Nutrition 0.000 claims abstract description 9
- 239000008101 lactose Substances 0.000 claims abstract description 9
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims abstract description 5
- 239000000706 filtrate Substances 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- 239000008187 granular material Substances 0.000 claims description 30
- 238000001035 drying Methods 0.000 claims description 25
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 24
- 239000012141 concentrate Substances 0.000 claims description 24
- AZHSSKPUVBVXLK-UHFFFAOYSA-N ethane-1,1-diol Chemical compound CC(O)O AZHSSKPUVBVXLK-UHFFFAOYSA-N 0.000 claims description 24
- 238000000227 grinding Methods 0.000 claims description 24
- 238000010992 reflux Methods 0.000 claims description 24
- 239000013049 sediment Substances 0.000 claims description 24
- 230000001476 alcoholic effect Effects 0.000 claims description 15
- 244000269722 Thea sinensis Species 0.000 claims description 12
- 235000009569 green tea Nutrition 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 12
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 12
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 10
- 229940013618 stevioside Drugs 0.000 claims description 10
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229960001375 lactose Drugs 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000007560 sedimentation technique Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 208000019693 Lung disease Diseases 0.000 abstract description 3
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 238000012423 maintenance Methods 0.000 abstract description 3
- 206010013911 Dysgeusia Diseases 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 235000009815 Momordica Nutrition 0.000 abstract 1
- 241000218984 Momordica Species 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 241001412231 Scaphium <angiosperm> Species 0.000 abstract 1
- 239000004383 Steviol glycoside Substances 0.000 abstract 1
- 230000035622 drinking Effects 0.000 abstract 1
- 229930182488 steviol glycoside Natural products 0.000 abstract 1
- 235000019411 steviol glycoside Nutrition 0.000 abstract 1
- 150000008144 steviol glycosides Chemical class 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 13
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 238000007605 air drying Methods 0.000 description 8
- 239000011230 binding agent Substances 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001835 salubrious effect Effects 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-N sodium;hydron;carbonate Chemical compound [Na+].OC(O)=O UIIMBOGNXHQVGW-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010049040 Weight fluctuation Diseases 0.000 description 1
- 238000010669 acid-base reaction Methods 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000007516 brønsted-lowry acids Chemical class 0.000 description 1
- 150000007528 brønsted-lowry bases Chemical class 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/40—Effervescence-generating compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses effervescent tablets with a lung heat clearing function. The effervescent tablets comprise components in percentage by mass as follows: 5%-15% of a grosvenor momordica fruit and boat-fruited scaphium seed mixed extract, 5%-8% of a fragrant solomonseal rhizome extract, 3%-8% of a semen arecae extract, 5%-10% of a green tea extract, 2%-5% of sodium alginate, 15%-25% of citric acid, 10%-15% of sodium bicarbonate, 10%-40% of lactose, 3% of fumaric acid, 1%-2% of steviol glycoside, 3% of polyvinylpyrrolidone and 0.5%-1% of food flavor. The invention further discloses a preparation method of the effervescent tablets. The lung heat clearing food suitable for the modern fast-paced life mode is invented in combination of multiple compatible edible and medicinal raw materials and effervescent tablets as modern preparations. The effervescent tablets have the advantages that the effervescent tablets are portable, are instantly taken once brewed, taste sweet and fresh and are easily accepted, do not have side effects on a human body, have the lung heat clearing effect, can prevent and relieve lung disease, and are quite beneficial to lung maintenance after long-term drinking.
Description
Technical field
The invention belongs to food manufacture field, be specifically related to a kind of effervescent tablet with lung heat clearing function。
Background technology
Effervescent tablet be with suitable acid, alkali is for disintegrating agent and adds a kind of tablet that other raw material is made, put in water, there is violent chemical reaction in bronsted lowry acids and bases bronsted lowry, produce carbon dioxide, promoting a kind of novel troche that tablet disintegrate within the section time is dissolved, country GB/T29602-2013 " solid beverage " is to arrange it for specific type solid beverage。
Along with air-polluting aggravates, pulmonary and respiratory tract disease are in ascendant trend year by year, and wherein pulmonary carcinoma has become the cancer that China's fatality rate is the highest。For modern, it should pay attention to pulmonary's maintenance。
Summary of the invention
It is an object of the invention to provide a kind of effervescent tablet with lung heat clearing function。
The technical scheme is that and be accomplished by:
A kind of effervescent tablet with lung heat clearing function; by weight/mass percentage composition, comprise Fructus Momordicae, Semen Sterculiae Lychnophorae mixed extract 5-15%, Rhizoma Polygonati Odorati extract 5 ~ 8%, Semen Arecae extract 3 ~ 8%, green tea extract 5 ~ 10%, sodium alginate 2-5%, citric acid 15 ~ 25%, sodium bicarbonate 10 ~ 15%, lactose 10 ~ 40%, fumaric acid 3%, stevioside 1 ~ 2%, polyvinylpyrrolidone 3%, essence for food 0.5 ~ 1%。
The preparation method that present invention also offers the above-mentioned effervescent tablet with lung heat clearing function, its step includes:
A, decoction and alcohol sedimentation technique prepare Fructus Momordicae, Semen Sterculiae Lychnophorae mixed extract, Rhizoma Polygonati Odorati extract, Semen Arecae extract and green tea extract respectively;
After B, citric acid are pulverized; granulate with the alcoholic solution of PVP; sodium bicarbonate, sodium alginate, lactose, stevioside mixing PVP alcoholic solution granulate; above granule weighs according to quantity; and weigh Fructus Momordicae, Semen Sterculiae Lychnophorae mixed extract powder, Rhizoma Polygonati Odorati extract powder, Semen Arecae extract powder, green tea extract powder, add fumaric acid and essence for food mix homogeneously tabletting, packaging。
In described step A, Fructus Momordicae, Semen Sterculiae Lychnophorae add 6 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.15 ~ 1.20%, add 95% ethanol alcohol and form sediment, concentrate, drying under reduced pressure powdering。
Further, in described step A, Rhizoma Polygonati Odorati adds 6 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.15 ~ 1.20%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
Further, in described step A, Semen Arecae adds 8 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
Further, in described step A, green tea adds 8 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
Further, the alcoholic solution of described PVP is ethanol containing 3%PVP and the water volume mixture with 9:1。
The present invention, with the material combination of multiple medicine-food two-purpose, has invented the lung heat clearing food of a kind of applicable modern fast pace life style in conjunction with effervescent tablet this Modern preparations mode。The effervescent tablet of the present invention has easy to carry, and with bubble with drink, taste and sweet mouthfeel is salubrious, and human body is had no side effect, has the effect of lung heat clearing, can prevent and alleviate pulmonary disease by the advantage being willing to accept, and long-term drink is highly beneficial to pulmonary's maintenance。
Fructus Momordicae feeble QI, taste is sweet, has effect of clearing heat and moistening lung, laxation relieving constipation, for lung-fire cough caused by dryness, pharyngalgia aphonia, dryness of the intestine constipation。
Semen Sterculiae Lychnophorae is lightly seasoned micro-sweet, cool in nature, has heat clearing away, lung moistening, sore-throat relieving, effect of removing toxic substances。
Rhizoma Polygonati Odorati sweet in the mouth, flat, there is yin nourishing, lung heat clearing, moisturize, relieving restlessness, the effect quenched the thirst。
Semen Arecae bitter in the mouth is pungent, temperature, puckery, cures mainly all gas, for miasma of dispelling, broken stagnant gas, dissipating depression of QI gas, lower mental disorder, removes pneumatosis, solves legendary venomous insect gas, rapid digestion of food gas, discharging the water pathogen, dissipates the medicine of beriberi, parasite killing gas, logical upper gas, alleviating distention in middle-JIAO gas, diarrhea gas。The cool property of Fructus Momordicae, Semen Sterculiae Lychnophorae and green tea can be neutralized。
Green tea is considered as state's drink in China, having refreshes oneself clears away heart-fire, clearing away summer-heat, eliminate indigestion and phlegm, go greasy fat-reducing, the relieving restlessness that clears away heart-fire, removing toxic substances relieving alcoholic intoxication, promoting the production of body fluid to quench thirst, pathogenic fire reducing improving eyesight, dysentery relieving dehumidifying effect。
Sodium alginate is natural polysaccharide, there is stability, dissolubility, viscosity and safety, use as stabilizer, thickening agent, emulsifying agent, dispersant, gellant, fruit glaze agent, suspending agent at modern industry, it it is the indispensable a kind of dietary fiber of human body simultaneously, there is unique threpsology's function, can the harmful substance that sucked by lung of complexation, clean alveolar, reduce metabolic waste in blood, it is also possible to improve digestion and the absorption of nutrient substance。
Stevioside is a kind of glucosides extracted from the leaf of Folium Stevlae Rebaudianae, as a kind of safe and reliable non-nutritive sweetener, there is high sugariness, feature low in calories, its sugariness is 200-300 times of sucrose, and heat is only 1/the 300 of sucrose, through experimental results demonstrate, stevioside has no side effect, non-carcinogenesis, and can prophylaxis of hypertension, diabetes, obesity, dental caries etc., be the desirably generation sugar sweeting agent of a kind of natural origin。
In effervescent tablet, effervescent is citric acid and sodium bicarbonate, and violent chemical reaction occurs in water for citric acid and sodium bicarbonate, produces carbon dioxide, citric acid and the amount of sodium bicarbonate and the CO in effervescent tablet in certain volume water2Generation amount be directly proportional, the best aerogenesis of citric acid and sodium bicarbonate ratio is for 0.76:1, but now about aqueous ph value neutrality, mouthfeel is poor, and in order to adjust mouthfeel, the ratio of general citric acid and sodium bicarbonate is 0.9 ~ 1.7:1, and pH value is 4.5 ~ 5.0。CO2 is indispensable composition, CO in soda pop2Main Function in soda pop strengthens local flavor, moreover it is possible to bring, to people, mouthfeel of stopping。CO2Measuring more high, the reaction of effervescent tablet foaming effect is more violent。But while considering bubble effect, the sodium citrate produced in the beverage after also taking into account acid-base reaction, because sodium citrate can make beverage produce offending astringent taste, thus the aftertaste mouthfeel of beverage is produced important impact, therefore the consumption of citric acid and sodium bicarbonate is also unsuitable too high。Therefore citric acid of the present invention and the sodium bicarbonate consumption in effervescent tablet formula is sodium citrate 15 ~ 25%, sodium bicarbonate 10 ~ 15%。Bubbling acutely, the persistent period is longer。
Polyvinylpyrrolidone (PVP) is binding agent, convas tablet binding agent has PVP, sugar liquid, starch slurry, polyvinyl acetate copolymer, sodium carboxymethyl cellulose etc., the present inventor contrasts discovery by experiment, select sugar liquid as binding agent, dispensing citric acid powder is easily lumpd in granulation process, slow-drying, the dried granule also very easily moisture absorption。Selecting sodium carboxymethyl cellulose as binding agent, sodium carboxymethyl cellulose is difficult to dissolve at short notice, also easily lumps in pelletization, it is difficult to dries, is unsuitable for big production operation。PVP as binding agent, granule prevented from caking, dry rapidly, product dissolves rapidly。Therefore select 90% alcoholic solution containing 3%PVP as binding agent。
Fumaric acid is lubricant, the phenomenon such as during for avoiding industrialized production tablet weight fluctuation is big, sticking and slice difficulty, makes sheeting process be smoothed out, and granule must be added to lubricant before tabletting。Conventional lubricant has polyethylene glycol 6000, fumaric acid, sodium lauryl sulphate, silicon dioxide etc., although PEG6000 lubricity and resistance to bond are pretty good, but addition DeGrain below 3%, and foam during effervescent, can be produced, extend the effervescent time。Fumaric acid does not have hygroscopicity, and there is fabulous lubrication, fumaric acid itself is a kind of acid source, faintly acid, having salubrious tart flavour after dissolving, weak point is that water solublity is not as, and adds the fumaric acid tabletting of 3% and can be smoothed out, substantially without undissolved fumaric acid after effervescent, mouthfeel is salubriouser。Therefore selecting fumaric acid as the lubricant of effervescent tablet, mix with granule before tabletting, addition is 3%。
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described, but the present invention is not limited except as。
Embodiment 1:
The preparation method originally with the effervescent tablet of lung heat clearing effect:
1, producing extract: Fructus Momordicae 5 parts, Semen Sterculiae Lychnophorae 5 parts add 6 times amount water reflux, extract, 3 times, each 1 hour, extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.15 ~ 1.20%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering;
Rhizoma Polygonati Odorati adds 6 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.15 ~ 1.20%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
Semen Arecae adds 8 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
Green tea adds 8 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
2, granulating: after being pulverized by citric acid 15%, make granule with 90% alcoholic solution containing 3% polyvinylpyrrolidone (PVP), with 40 mesh sieve granulate, at 50 DEG C, forced air drying is to water content < 3%;Sodium bicarbonate 10%, lactose 39.5%, stevioside 1%, sodium alginate 2% are mixed, granule is made with 90% alcoholic solution containing 3% polyvinylpyrrolidone (PVP), with 40 mesh sieve granulate, at 50 DEG C, forced air drying is to water content < 3%, and making the content of polyvinylpyrrolidone in end-product is 3%。
3, tabletting: take above-mentioned two kinds of dry granules and mix homogeneously with Fructus Momordicae, Semen Sterculiae Lychnophorae mixed extract 5%, Rhizoma Polygonati Odorati extract 5%, Semen Arecae extract 6%, green tea extract 10%, Green tea essence 0.5% and fumaric acid 3%, enter tabletting machine, every 4 grams。
4, packaging: the effervescent tablet pressed is packed, 20 every bottle。
The effervescent tablet monolithic that the present invention makes weighs 4 grams, uniform color, and hardness is moderate, is dissolved in 200ml warm water or cold water, sour and sweet palatability, and CO2 is sufficient, mouthfeel of stopping, and has the Fructus Lycii fragrance of gentleness。And use through osteoporosis person, it was demonstrated that there is good lung heat clearing effect。
The effect of the effervescent tablet that above-described embodiment prepares is carried out efficacy detection, chooses more than one week patient of 30 example persistent cough, wherein male 11 example, women 19 example;At 30 50 years old age, every patient takes the effervescent tablet 3 ~ 5 of the embodiment of the present invention 1 every day, continues 20 days, and 26 example patients cough stoppings, and 2 example patients cough and alleviate。
Embodiment 2:
The preparation method originally with the effervescent tablet of lung heat clearing effect:
1, producing extract: Fructus Momordicae 9 parts, Semen Sterculiae Lychnophorae 1 part add 6 times amount water reflux, extract, 3 times, each 1 hour, extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.15 ~ 1.20%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering;
Rhizoma Polygonati Odorati adds 6 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.15 ~ 1.20%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
Semen Arecae adds 8 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
Green tea adds 8 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
2, granulating: after being pulverized by citric acid 25%, make granule with 90% alcoholic solution containing 3% polyvinylpyrrolidone (PVP), with 40 mesh sieve granulate, at 50 DEG C, forced air drying is to water content < 3%;Sodium bicarbonate 15%, lactose 15%, stevioside 2%, sodium alginate 5% are mixed, granule is made with 90% alcoholic solution containing 3% polyvinylpyrrolidone (PVP), with 40 mesh sieve granulate, at 50 DEG C, forced air drying is to water content < 3%, and making the content of polyvinylpyrrolidone in end-product is 3%。
3, tabletting: take above-mentioned two kinds of dry granules and mix homogeneously with Fructus Momordicae, Semen Sterculiae Lychnophorae mixed extract 10%, Rhizoma Polygonati Odorati extract 8%, Semen Arecae extract 8%, green tea extract 5%, Green tea essence 1% and fumaric acid 3%, enter tabletting machine, every 4 grams。
4, packaging: the effervescent tablet pressed is packed, 20 every bottle。
The effect of the effervescent tablet that above-described embodiment prepares is carried out efficacy detection, chooses more than one week patient of 30 example persistent cough, wherein male 18 example, women 12 example;At 30 50 years old age, every patient takes the effervescent tablet 3 ~ 5 of the embodiment of the present invention 1 every day, continues 20 days, and 27 example patients cough stoppings, and 3 example patients cough and alleviate。
Embodiment 3:
The preparation method originally with the effervescent tablet of lung heat clearing effect:
1, producing extract: Fructus Momordicae 5 parts, Semen Sterculiae Lychnophorae 5 parts add 6 times amount water reflux, extract, 3 times, each 1 hour, extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.15 ~ 1.20%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering;
Rhizoma Polygonati Odorati adds 6 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.15 ~ 1.20%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
Semen Arecae adds 8 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
Green tea adds 8 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
2, granulating: after being pulverized by citric acid 20%, make granule with 90% alcoholic solution containing 3% polyvinylpyrrolidone (PVP), with 40 mesh sieve granulate, at 50 DEG C, forced air drying is to water content < 3%;Sodium bicarbonate 12%, lactose 24.5%, stevioside 1.5%, sodium alginate 3.2% are mixed, granule is made with 90% alcoholic solution containing 3% polyvinylpyrrolidone (PVP), with 40 mesh sieve granulate, at 50 DEG C, forced air drying is to water content < 3%, and making the content of polyvinylpyrrolidone in end-product is 3%。
3, tabletting: take above-mentioned two kinds of dry granules and mix homogeneously with Fructus Momordicae, Semen Sterculiae Lychnophorae mixed extract 15%, Rhizoma Polygonati Odorati extract 6%, Semen Arecae extract 3%, green tea extract 8%, Green tea essence 0.8% and fumaric acid 3%, enter tabletting machine, every 4 grams。
4, packaging: the effervescent tablet pressed is packed, 20 every bottle。
The effect of the effervescent tablet that above-described embodiment prepares is carried out efficacy detection, chooses more than one week patient of 30 example persistent cough, wherein male 14 example, women 16 example;At 30 50 years old age, every patient takes the effervescent tablet 3 ~ 5 of the embodiment of the present invention 1 every day, continues 20 days, and 25 example patients cough stoppings, and 2 example patients cough and alleviate。
Embodiment 4:
The preparation method originally with the effervescent tablet of lung heat clearing effect:
1, producing extract: Fructus Momordicae 1 part, Semen Sterculiae Lychnophorae 9 parts add 6 times amount water reflux, extract, 3 times, each 1 hour, extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.15 ~ 1.20%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering;
Rhizoma Polygonati Odorati adds 6 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.15 ~ 1.20%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
Semen Arecae adds 8 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
Green tea adds 8 times amount water reflux, extract, 3 times, each 1 hour, and extracting solution filters, and filtrate merges, and filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
2, granulating: after being pulverized by citric acid 25%, make granule with 90% alcoholic solution containing 3% polyvinylpyrrolidone (PVP), with 40 mesh sieve granulate, at 50 DEG C, forced air drying is to water content < 3%;Sodium bicarbonate 15%, lactose 10%, stevioside 2%, sodium alginate 4% are mixed, granule is made with 90% alcoholic solution containing 3% polyvinylpyrrolidone (PVP), with 40 mesh sieve granulate, at 50 DEG C, forced air drying is to water content < 3%, and making the content of polyvinylpyrrolidone in end-product is 3%。
3, tabletting: take above-mentioned two kinds of dry granules and mix homogeneously with Fructus Momordicae, Semen Sterculiae Lychnophorae mixed extract 15%, Rhizoma Polygonati Odorati extract 7.5%, Semen Arecae extract 5%, green tea extract 10%, Green tea essence 0.5% and fumaric acid 3%, enter tabletting machine, every 4 grams。
4, packaging: the effervescent tablet pressed is packed, 20 every bottle。
The effect of the effervescent tablet that above-described embodiment prepares is carried out efficacy detection, chooses more than one week patient of 30 example persistent cough, wherein male 15 example, women 15 example;At 30 50 years old age, every patient takes the effervescent tablet 3 ~ 5 of the embodiment of the present invention 1 every day, continues 20 days, and 26 example patients cough stoppings, and 3 example patients cough and alleviate。
Claims (7)
1. an effervescent tablet with lung heat clearing function; it is characterized in that by weight/mass percentage composition, comprise Fructus Momordicae, Semen Sterculiae Lychnophorae mixed extract 5-15%, Rhizoma Polygonati Odorati extract 5 ~ 8%, Semen Arecae extract 3 ~ 8%, green tea extract 5 ~ 10%, sodium alginate 2-5%, citric acid 15 ~ 25%, sodium bicarbonate 10 ~ 15%, lactose 10 ~ 40%, fumaric acid 3%, stevioside 1 ~ 2%, polyvinylpyrrolidone 3%, essence for food 0.5 ~ 1%。
2. a preparation method with the effervescent tablet of lung heat clearing function, its step includes:
A, decoction and alcohol sedimentation technique prepare Fructus Momordicae, Semen Sterculiae Lychnophorae mixed extract, Rhizoma Polygonati Odorati extract, Semen Arecae extract and green tea extract respectively;
After B, citric acid are pulverized; granulate with the alcoholic solution of PVP; sodium bicarbonate, sodium alginate, lactose, stevioside mixing PVP alcoholic solution granulate; above granule weighs according to quantity; and weigh Fructus Momordicae, Semen Sterculiae Lychnophorae mixed extract powder, Rhizoma Polygonati Odorati extract powder, Semen Arecae extract powder, green tea extract powder, add fumaric acid and essence for food mix homogeneously tabletting, packaging。
3. the preparation method of the effervescent tablet with lung heat clearing function according to claim 2, it is characterized in that: in described step A, Fructus Momordicae, Semen Sterculiae Lychnophorae add 6 times amount water reflux, extract, 3 times, each 1 hour, extracting solution filters, filtrate merges, filtrate is concentrated into relative density 1.15 ~ 1.20%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
4. the preparation method of the effervescent tablet with lung heat clearing function according to claim 2, it is characterized in that: in described step A, Rhizoma Polygonati Odorati adds 6 times amount water reflux, extract, 3 times, each 1 hour, extracting solution filters, filtrate merges, filtrate is concentrated into relative density 1.15 ~ 1.20%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
5. the preparation method of the effervescent tablet with lung heat clearing function according to claim 2, it is characterized in that: in described step A, Semen Arecae adds 8 times amount water reflux, extract, 3 times, each 1 hour, extracting solution filters, filtrate merges, filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
6. the preparation method of the effervescent tablet with lung heat clearing function according to claim 2, it is characterized in that: in described step A, green tea adds 8 times amount water reflux, extract, 3 times, each 1 hour, extracting solution filters, filtrate merges, filtrate is concentrated into relative density 1.10 ~ 1.15%, adds 95% ethanol alcohol and forms sediment, concentrates, drying under reduced pressure powdering。
7. the preparation method of the effervescent tablet with lung heat clearing function according to any one of claim 2-6, it is characterised in that: the alcoholic solution of described PVP is ethanol containing 3%PVP and the water volume mixture with 9:1。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610138972.6A CN105685759A (en) | 2016-03-13 | 2016-03-13 | Effervescent tablets with lung heat clearing function and preparation method of effervescent tablets |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610138972.6A CN105685759A (en) | 2016-03-13 | 2016-03-13 | Effervescent tablets with lung heat clearing function and preparation method of effervescent tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105685759A true CN105685759A (en) | 2016-06-22 |
Family
ID=56220330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610138972.6A Pending CN105685759A (en) | 2016-03-13 | 2016-03-13 | Effervescent tablets with lung heat clearing function and preparation method of effervescent tablets |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105685759A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1088393A (en) * | 1992-12-24 | 1994-06-29 | 沈在中 | The processing method of tea of throat care |
CN103907707A (en) * | 2014-03-14 | 2014-07-09 | 南京融点食品科技有限公司 | Grosvenor-momordica-fruit lung-clearing tea and preparation method thereof |
CN105381019A (en) * | 2015-11-19 | 2016-03-09 | 南京优能生物科技有限公司 | Effervescent tablet with internal-fire clearing function and preparation method thereof |
-
2016
- 2016-03-13 CN CN201610138972.6A patent/CN105685759A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1088393A (en) * | 1992-12-24 | 1994-06-29 | 沈在中 | The processing method of tea of throat care |
CN103907707A (en) * | 2014-03-14 | 2014-07-09 | 南京融点食品科技有限公司 | Grosvenor-momordica-fruit lung-clearing tea and preparation method thereof |
CN105381019A (en) * | 2015-11-19 | 2016-03-09 | 南京优能生物科技有限公司 | Effervescent tablet with internal-fire clearing function and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018058851A1 (en) | Siraitia grosvenorii-prebiotics-chrysanthemum instant tea beverage and preparation method therefor | |
CN101264177B (en) | Tablet forming candy with refreshing, pharynx-clearing and throat-smoothing action | |
CN107594272A (en) | A kind of warm the womb menstruation regulating, the health drink for nourishing beauty treatment and preparation method thereof | |
KR101326005B1 (en) | Functional beverage composition comprising Panax Ginseng concentrate and fruit concentrate | |
CN106509572A (en) | Solid drink containing honeysuckles and preparation method thereof | |
CN105381019A (en) | Effervescent tablet with internal-fire clearing function and preparation method thereof | |
CN110313597A (en) | One kind is instant to be exempted to rush throat soothing particle and preparation method thereof | |
CN107927263A (en) | A kind of preparation method of radix tetrastigme " Luohan " fruit tea | |
CN104115960A (en) | Fresh reed rhizome herbal tea beverage | |
CN103535468A (en) | Formula and production method of pine nut bowel relaxing tea | |
CN106307212A (en) | Vegetable and fruit porridge for relieving cold | |
CN101455694A (en) | American ginseng nutrient effervescence decoction pieces and manufacture technique thereof | |
CN105685759A (en) | Effervescent tablets with lung heat clearing function and preparation method of effervescent tablets | |
CN108157975A (en) | A kind of vitamin C effervescent tablet | |
CN107668464A (en) | A kind of sweet mung bean soup effervescent tablet | |
CN106616126A (en) | Functional radix glehniae drink and preparation method thereof | |
CN110301635A (en) | A kind of emblic oral instant particle and preparation method | |
CN107467287A (en) | A kind of tea for reducing hypertension and fat | |
CN106165815A (en) | A kind of dispersing lung-QI and dissipating phlegm antiasthmatic-antitussive beverage and preparation processing method | |
CN111789206A (en) | Loquat beverage preparation and preparation method thereof | |
CN107361281B (en) | Momordica grosvenori effervescent tablet and preparation method thereof | |
CN105639517A (en) | Loquat lotion and preparation method thereof | |
CN101322571A (en) | Method for producing coffee-imitating effervescence hypoglycemic drink from Arctium lappa and bitter melon | |
CN108782901A (en) | A kind of fruit herbal tea powder and preparation method thereof | |
CN116492437B (en) | Plant buccal tablet for improving respiratory tract immunity and preparation process thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160622 |